PR Newswire Clinical TrialsOriginal article
CaseBioscience® schließt sich einem Team an, das von ARPA-H bis zu 7,3 Millionen US-Dollar für die Weiterentwicklung der Lagerung von Zelltherapien bei Raumtemperatur erhält
PartnershipPositive
AI Analysis
Summary
CaseBioscience announced participation in an ARPA-H-funded multidisciplinary team led by Likarda, receiving up to $7.3 million for developing room temperature storage solutions for cell therapies.
Outcome Details
Multidisciplinary team awarded up to $7.3 million for cell therapy room temperature storage development
Importance:5/10
Sentiment:
0.60
Cell therapyARPA-H fundingStorage technologyPartnership
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on October 3, 2026 12:35 AM
